CD4 and myeloid sarcoma: Nonetheless, previous studies focused on CD4+ T cell OxPhos dysfunction in patients with MS employing magnetic enrichment and fewer subjects than the present cohort were still successful in defining a clear mitochondrial phenotype9,47.